Call Now: +1 858 800 3101 Email: info@innopep.com
Shopping Cart
0 Item(s) - $0.00
Your shopping cart is empty!
Amylin (8 - 37), human
| Overview | |
|---|---|
| Description | This peptide selectively inhibits insulin-stimulated glucose utilization and glycogen deposition in muscle. |
| Sequence | ATQRLANFLVHSSNNFGAILSSTNVGSNTY-NH2 |
| Sequence (3 Letter) | H-Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-His-Ser-Ser-Asn-Asn-Phe-Gly-Ala-Ile-Leu-Ser-Ser-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr-NH2 |
| Molecular Weight | 3183.5 |
| Properties | |
| Purity | > 95% By HPLC |
| Storage | Store at -20 °C, cap vial tightly at all times. |
Ref: Van Mansfeld, ADM. et al. Biochem. Biophys. Acta. 1087, 235 (1990); Deems, RO. et al. Biochem. Biophys. Res. Commun. 181, 116 (1991).
About InnoPep
InnoPep Inc. is a company started by a couple of researchers with decades of expertise in peptide synthesis and conjugation aimed at enabling.